Evidence map›Paper›PMID 20194788›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

In vivo gene delivery by cationic tetraamino fullerene.

Rui Maeda-Mamiya, Eisei Noiri, Hiroyuki Isobe, Waka Nakanishi, Koji Okamoto, Kent Doi, Takeshi Sugaya, Tetsuro Izumi, Tatsuya Homma, Eiichi Nakamura

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 176 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Nanocarriers for cutting-edge cancer immunotherapies.Journal of translational medicine · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. CGeroScience · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Biological interactions of carbon-based nanomaterials: From coronation to degradation.Nanomedicine : nanotechnology, biology, and medicine · 2016
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rui Maeda-MamiyaDepartment of Chemistry and Exploratory Research for Advanced Technology (Japan Science and Technology Agency), University of Tokyo, 7-3-1 Hongo Bunkyo, Tokyo 113-0033, Japan.
Eisei Noiri
Hiroyuki Isobe
Waka Nakanishi
Koji Okamoto
Kent Doi
Takeshi Sugaya
Tetsuro Izumi
Tatsuya Homma
Eiichi Nakamura
University of Tokyo Hospital · JPThe University of Tokyo · JPTohoku University · JPGunma University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Application of nanotechnology to medical biology has brought remarkable success. Water-soluble fullerenes are molecules with great potential for biological use because they can endow unique characteristics of amphipathic property and form a self-assembled structure by chemical modification. Effective gene delivery in vitro with tetra(piperazino)fullerene epoxide (TPFE) and its superiority to Lipofectin have been described in a previous report. For this study, we evaluated the efficacy of in vivo gene delivery by TPFE. Delivery of enhanced green fluorescent protein gene (EGFP) by TPFE on pregnant female ICR mice showed distinct organ selectivity compared with Lipofectin; moreover, higher gene expression by TPFE was found in liver and spleen, but not in the lung. No acute toxicity of TPFE was found for the liver and kidney, although Lipofectin significantly increased liver enzymes and blood urea nitrogen. In fetal tissues, neither TPFE nor Lipofectin induced EGFP gene expression. Delivery of insulin 2 gene to female C57/BL6 mice increased plasma insulin levels and reduced blood glucose concentrations, indicating the potential of TPFE-based gene delivery for clinical application. In conclusion, this study demonstrated effective gene delivery in vivo for the first time using a water-soluble fullerene.

Indexed as

FullerenesGene Transfer TechniquesAnimalsBase SequenceDNA PrimersDNA, RecombinantFemaleFetusGene ExpressionGenetic TherapyGreen Fluorescent ProteinsInsulinMiceMice, Inbred C57BLMice, Inbred ICRNanotechnology1,2-dielaidoylphosphatidylethanolamineDNA PrimersDNA, Recombinantenhanced green fluorescent proteinFullerenesGreen Fluorescent ProteinsInsulinPhosphatidylethanolaminesRecombinant Proteinstetraamino fullereneWater

Identifiers

PMID20194788
PMCPMC2851755
OpenAlexW2111490558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.